PRKD1 and breast carcinoma: A comparison between 51 luminal and basal subtypes of breast cancer cell lines using GOBO from Lund University (http://co.bmc.lu.se/gobo/) [28] suggested a further (statistically significant) decrease in PRKD1 gene expression in breast cancers of the basal A type (Figure 4A).